Evidence-based medicine has been embraced as a practice to increase healthcare expenditures and as a tool to improve patient care, ensuring that patients receive the best resources for their care, without unnecessary and wasteful procedures. Clinical results are proving molecular imaging’s merits in a wider number of applications.
Healthcare legislation expected to reach the Senate floor this weekend is projected to cost $848 billion and reduce the federal budget deficit by $130 billion over 10 years, according to the Congressional Budget Office (CBO).
In a reversal of its 2002 recommendations, the U.S. Preventive Services Task Force (USPSTF) has issued new guidelines against routine screening mammography in women aged 40 to 49 years, against teaching women breast self-examination and advocating biennial screening mammography only for women aged 50 to 74 years.
Quality initiatives and reporting in healthcare on the private, state and federal level are growing and becoming increasingly more complex. In the past 10 years, the defining of and reporting on health quality metrics has expanded at an almost exponential rate. With Medicare reimbursement being more and more tied to quality both now and in the future, the focus of clinical, administrative and IT leaders is on how to improve the quality of patient care and prove it via sophisticated quality measures.
Time-resolved MR angiography (TR-MRA) is a useful sequence for the assessment of ovarian vein reflux, which may aid the evaluation of pelvic congestion syndrome, according to research published this month in the American Journal of Roentgenology.
The evaluation of a combination of rib-suppressed and original chest radiographs significantly improved the diagnostic performance of radiologists in the detection of pulmonary nodules, according to an observer study published this month in the American Journal of Roentgenology.
The pace of research in functional imaging moves at a fast clip, with breakthroughs at the laboratory bench promising new treatments in the clinical setting. Getting from point A to point B, however, is rarely a seamless transition. Take the biomarker 11C-choline, for example. The compound has successfully been applied for PET imaging of prostate cancer, bladder cancer and other solid malignancies. Although the radiotracer has shown strength for cancer detection, its observed sensitivity has shown great variance.
The fusion of 11C-choline PET data with high-resolution anatomic imaging (such as future hybrid PET/MRI systems) may offer the potential to guide targeted prostate biopsies and to noninvasively select high-risk prostate cancer patients for definitive treatments such as surgery or radiotherapy, according to research published in the October issue of the Journal of Nuclear Medicine.
A single breath hold of 20 seconds can enable more precise measurements of maximum standardized uptake value, especially in the lower lung field and for small tumors--which may be affected by respiratory motion--according to research published in this months Journal of Nuclear Medicine.